Early weight gain predicts outcome in two treatments for adolescent anorexia nervosa. by Le Grange, Daniel et al.
UCSF
UC San Francisco Previously Published Works
Title
Early weight gain predicts outcome in two treatments for adolescent anorexia nervosa.
Permalink
https://escholarship.org/uc/item/9hz412j2
Journal
The International journal of eating disorders, 47(2)
ISSN
0276-3478
Authors
Le Grange, Daniel
Accurso, Erin C
Lock, James
et al.
Publication Date
2014-03-01
DOI
10.1002/eat.22221
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
Early Weight Gain Predicts Outcome in Two Treatments for 
Adolescent Anorexia Nervosa
Daniel Le Grange, PhD1,*, Erin C. Accurso, PhD1, James Lock, MD, PhD2, Stewart Agras, 
MD2, and Susan W. Bryson, MS2
1The University of Chicago, Department of Psychiatry and Behavioral Neuroscience, Chicago, IL
2Stanford University, Department of Psychiatry and Behavioral Sciences, Stanford, CA
Abstract
Objective—Determine whether early weight gain predicts full remission at end-of-treatment 
(EOT) and follow-up in two different treatments for adolescent anorexia nervosa, and to track the 
rate of weight gain throughout treatment and follow-up.
Method—Participants were 121 adolescents with AN (mean age = 14.4 years, SD = 1.6), from a 
two-site (Chicago and Stanford) randomized controlled trial. Adolescents were randomly assigned 
to family-based treatment (FBT) (n=61) or individual adolescent supportive psychotherapy (AFT) 
(n=60). Treatment response was assessed using percent of expected body weight (EBW) and the 
global score on the Eating Disorder Examination (EDE). Full remission was defined as having 
achieved ≥95% EBW and within one standard deviation of the community norms of the EDE. Full 
remission was assessed at EOT as well as 12-month follow-up.
Results—Receiver operating characteristic analyses showed that the earliest predictor of 
remission at EOT was a gain of 5.8 pounds (2.65 kg) by session 3 in FBT (AUC = .670; p=.043), 
and a gain of 7.1 pounds (3.20 kg) by session 4 in AFT (AUC=0.754, p=.014). Early weight gain 
did not predict remission at follow-up for either treatment. A survival analysis showed that weight 
was marginally superior in FBT as opposed to AFT (Wald chi-square=3.692, df=1, p=.055).
Conclusion—Adolescents with AN who receive either FBT or AFT, and show early weight 
gain, are likely to remit at EOT. However, FBT is superior to AFT in terms of weight gain 
throughout treatment and follow-up.
Keywords
adolescent anorexia nervosa; family-based treatment; adolescent focused therapy; early treatment 
response
Early change in treatment is a promising clinical indicator of treatment outcome in patients 
with eating disorders. For instance, examining weight gain trajectories for adult patients 
with anorexia nervosa (AN) in an inpatient setting, demonstrated that gains at weeks 3 and 4 
accurately classified a majority of treatment responders vs. non-responders (1). For bulimia 
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nervosa (BN), it has been shown that early change in binge eating and purging among 
adolescents receiving FBT or individual supportive therapy is a good predictor of response 
at the end of treatment (2). Early reduction in these behaviors among adults who receive 
cognitive behavior therapy (CBT) is also a good predictor of end of treatment response (3). 
In this study, Fairburn and colleagues demonstrated that early change in treatment is a robust 
predictor of immediate outcome and long-term outcome in BN. In adolescent AN, two 
published reports have investigated early response to outpatient treatment with family-based 
treatment (FBT) as a predictor of outcome. In the first, Lock and colleagues (4) showed that 
weight gain by sessions 2, 9, or 10 in a sample of 86 adolescents was predictive of a positive 
outcome. Participants received one of two doses of FBT delivered in the context of a 
randomized controlled trial (RCT). In the second, Doyle and colleagues (5) expanded these 
findings and examined the utility of early weight response in predicting outcome for a clinic 
sample of adolescents with AN. They showed that weight gain of 4 pounds by session 4 best 
predicted outcome (>95% of expected body weight [EBW]) at the end of a course of FBT.
Hence, to date, early change in weight has only been examined for FBT. Therefore, the 
primary objective of the present study was to determine whether early weight gain predicts 
full remission at the end of treatment and at follow-up for both FBT and an individual 
treatment in a sample of adolescents who participated in a recently published RCT (6). A 
secondary objective was to examine the rate of weight change during treatment and the 
follow-up period.
METHODS
Data are from a two-site RCT (The University of Chicago and Stanford University) that 
compared family-based treatment (FBT) and individual adolescent focused therapy (AFT). 
Adolescents (n=121) meeting DSM-IV criteria for AN, excluding criterion D, were 
randomly assigned to either FBT or AFT. Both treatments lasted 12 months, and all 
participants received 24 hours of therapy, regardless of treatment modality. Assessments 
were conducted at baseline, end-of-treatment (EOT), and at 6- and 12-month follow-up. The 
Institutional Review Boards of The University of Chicago and Stanford University approved 
this study, and all participants and participation involved informed consent. Details of this 
design, main outcome findings, and moderator/mediator analyses are reported elsewhere 
(6,7).
Statistical Analyses
IBM SPSS Statistics 19 was used for all analyses. To examine if early weight gain in 
treatment was predictive of remission status, we conducted receiver operating characteristic 
(ROC) analyses with a nonparametric distribution assumption and choosing cut-points to 
achieve equal sensitivity and specificity. We evaluated the association between weight gain, 
i.e., the difference in pounds between baseline and sessions 1 through 8, and remission 
status at EOT and at 12-month follow-up. The ROC area under the curve (AUC) and 
corresponding 95% confidence interval were utilized to evaluate the relationship between 
weight gain and remission. The AUC represents the probability that a randomly selected 
participant who achieved remission, would have reached a higher weight at that session than 
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a randomly selected participant who had not remitted. The main outcome analyses are 
originally reported elsewhere but will be briefly reiterated here. Details of the mixed-effects 
modeling analyses and number needed to treat (NNT) effect size calculations are available 
in the original reports (6,7). Using the cut-points determined in the ROC, independent t- and 
chi-square tests were used to compare individuals who had achieved the ROC weight gain 
cut-point versus those who had not.
Evaluating the time to achieve at least 95% EBW was performed using survival analyses 
(8,9). Weight data were available at 3 months, 6 months, 9 months, EOT, 6-month follow-up 
(18 months), and 12-month follow-up (24 months). Individuals with no follow-up data (n=8, 
6.6%), those with limited within-treatment data due to treatment drop-out (n=11, 9.1%), and 
those who completed follow-up assessments but did not achieve 95% EBW by the final time 
point (i.e., 12-month follow-up; n=29, 24.0%) were treated as “censored” observations, 
indicating that treatment response did not occur prior to termination of the measurement 
period. A Cox proportional hazard model was then fitted using a log logistic distribution. 
Indicator variables, coded as −.5 and +.5 were created to represent treatment group, 
treatment center, and treatment by center interaction (10); an overall coefficient for 
treatment group was obtained. Finally, for individuals who had achieved 95% EBW at any 
point in the 24 month period, independent t- and chi-square tests were used to compare those 
who achieved this weight within 6 months versus those achieved it after 6 months.
RESULTS
Participant Characteristics
Participants were predominantly female (90.9%) with a mean age of 14.4 years (SD = 1.6). 
Race/ethnicity was largely non-Hispanic White (76%, n=92), but also Hispanic White 
(7.4%, n=9), Asian (10.7%, n=13), Black (0.8%, n=1), and ‘other’ (5.0%, n=6). Mean 
%EBW was 80.4% (SD = 3.6) with a mean BMI of 16.1 (SD = 1.1) using the Centers for 
Disease Control and Prevention growth charts; 17.4% (n=21) reported purging behavior. 
Average duration of illness was 11.3 months (SD=8.6), with 44.6% (n=54) of the sample 
reporting prior hospitalization for AN or medical problems associated with AN. 
Approximately one quarter of participants (24.5%, n=29) met criteria for a current comorbid 
psychiatric disorder by the Schedule for Affective Disorders and Schizophrenia for School-
Aged Children, and 16.5% (n=20) were taking psychotropic medications at baseline. 
Families were mostly intact (78.9%, n=95) and most parents had attended some higher 
education (means of 15.7 and 16.2 years of education for mothers and fathers, respectively). 
Remission data were available at end of treatment (n=103, 85.5%), 6-month follow-up 
(n=88, 72.7%), and 12-month follow-up (n=93, 76.9%). Compared to those with data at 
EOT, adolescents with missing data were more likely to take a psychotropic medication at 
baseline (33.3% v. 13.6%; φ =−.19, p=.037). There were no other differences for those with 
missing data at EOT, 6-month follow-up, or 12-month follow-up.
Treatment Outcomes
Remission was defined as reaching at least 95% EBW and scoring within 1 SD of 
community norms on the EDE (6,7). Briefly, there were no statistical differences in 
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remission between treatments at EOT (FBT = 42% vs. AFT = 23%, p=.055; NNT=5). 
However, at both 6-month follow-up (FBT = 40% vs. AFT = 18%, p=.029; NNT=5), and 
12-month follow-up (FBT = 49% vs. AFT = 23%, p=.024; NNT=4), FBT was significantly 
superior to AFT on this measure.
Early Weight Gain and Remission
ROC curves for adolescents receiving FBT (n=50) revealed that weight gain at sessions 3 
through 8 was significantly associated with EOT remission status (p<.05), with AUC values 
ranging from 0.670 to 0.929 (see Table 1a). The earliest predictor of EOT remission was 
gaining at least 5.8 pounds (2.65 kg) by session 3 (AUC=0.670, p=.043; 42.6% met 
threshold). The strongest predictor of EOT remission was gaining at least 11.2 pounds by 
session 8 (AUC=0.929, p=.010; 13.1%). ROC curves for adolescents receiving AFT (n=53) 
revealed that weight gain at sessions 4 through 6 was significantly associated with EOT 
remission status (p< 0.05), with AUC values for those sessions ranging from 0.739 to 0.791 
(see Table 1a). The earliest predictor of EOT remission was gaining at least 7.1 pounds 
(3.20 kg) by session 4 (AUC=0.754, p=.014; 35.0%), although weight gain of at least 5.1 
pounds by session 3 was marginally significant (AUC=0.687, p=.058; 38.3%). The strongest 
predictor of EOT remission was gaining at least 7.8 pounds by session 5 (AUC=0.791, p=.
007; 35.0%). The earliest session for which ROC curves were significant across treatment 
types was session 4. None of the ROC curves were significantly associated with remission at 
12-month follow-up for adolescents in FBT (n=44) or AFT (n=49) (see Table 1b).
Early Treatment Responders versus Non-early Responders
Early treatment responders (i.e., those gaining ≥5.8 pounds at FBT session 3, or ≥7.1 pounds 
at AFT session 4) were compared to non-early responders. Participants who had missing 
weight data due to psychotherapy non-attendance were assumed to not have met the weight 
gain criterion (n=6 in FBT, n=5 in AFT). Compared to non-early FBT responders, early 
FBT responders (n=27, 44.3%) differed at baseline only in their parents’ education level, 
such that early FBT responders had parents with fewer years of education (15.9 vs. 17.2; 
t58.3=−2.1, p=.045). There were no other baseline differences between non-early and early 
FBT responders (ps > .10). Compared to adolescents without early response to AFT, early 
AFT responders (n=21, 35.0%) were more likely to have no comorbidity (85.7% vs. 59.0%; 
φ=−.27, p=.034), and although not statistically significant, appeared to be more likely to 
have an intact family (90.5% vs. 69.2%; φ=.24, p=.063). There were no other baseline 
differences between early AFT responders v. non-early responders (ps > .10). Treatment 
group (AFT vs. FBT) was not significantly associated with early treatment-specific 
response.
Timely versus Slow Weight Gain
A majority of participants achieved 95% EBW at one point within two years of initiating 
treatment (n=74, 61.2%) - approximately two-thirds (67.2%, n=41) of those who received 
FBT and more than half (55.0%, n=33) of those who received AFT. Baseline characteristics 
were compared between adolescents who achieved 95% EBW within the first 6 months of 
treatment (timely: n=55, 45.5%) to those who achieved 95% EBW at any point between 6 
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months and one-year follow-up (slow: n=19, 15.7%). Participants who failed to achieve 95% 
EBW (n=47, 38.8%) were excluded from this analysis. At baseline, adolescents with timely 
weight restoration differed from those with slow weight restoration in that the former were 
more likely to be male (81.8% vs. 41.8%; φ=.23, p=.037), and had more problematic family 
functioning (2.1 vs. 1.8; t71=2.1, p=.036).
Rate of Weight Gain Throughout Treatment and Follow-up
Weight data were available at 3 months, 6 months, 9 months, EOT, 6-month follow-up (18 
months), and 12-month follow-up (24 months). Controlling for center and center by 
treatment interaction, time to 95% EBW was marginally associated with treatment group, 
such that adolescents receiving FBT achieved 95% EBW sooner than adolescents receiving 
AFT (Wald chi-square=3.692, df=1, p=.055, OR=1.6, 95% CI=1.0–2.5). At all within-
treatment and follow-up points, a greater percentage of individuals who received FBT 
achieved 95% EBW compared to AFT. Figure 1 depicts time to reach 95% EBW, where the 
vertical axis represents the survival function, or the proportion of non-responders as defined 
by achieving less than 95% EBW.
DISCUSSION
Early weight gain in both treatments predicted remission at EOT. ROC analyses showed that 
weight gain of more than 5 pounds by session 3 of FBT predicted remission at EOT, and 
weight gain of more than 7 pounds by session 4 of AFT predicted remission at EOT. Early 
weight gain was not predictive of remission at 12-month follow-up in either treatment. This 
suggests that early weight gain is not essential for remission at follow-up, although it is 
likely to minimize the medical and psychological consequences resulting from acute 
starvation. However, in a recent study, achievement of 95% EBW at the end FBT was 
predictive of remission (11). Taken together, these findings support the notion that early 
weight gain predicts EOT weight restoration to 95% EBW, while EOT weight restoration 
predicts long-term recovery. Few baseline variables distinguished early weight responders 
from non-responders, regardless of treatment. However, some variables predicted 
achievement of 95% EBW within 6 months (timely) as compared to a slow weight response, 
that is, male gender, greater family disadvantages and engaging in purging.
A survival analysis of the time to achieve at least 95% EBW showed that FBT added more 
participants to this marker at every time point throughout treatment and follow-up. In other 
words, adolescents in FBT tended to gain weight more rapidly and more consistently than 
their counterparts in AFT. Nevertheless, both treatments were limited to some extent in their 
efficacy across individuals, with more than one third of adolescents failing to reach 95% 
EBW at any time point assessed in a two-year period. While weight gain is only one 
component of treatment and does not equate with remission, these findings add to the 
growing body of literature showing that patients with early weight gain are more likely to be 
responders at post-treatment (4,5). It also extends the limited prior work in adolescents with 
AN in that it offers a comparison between FBT and AFT, showing that early weight gain in 
both treatments predicts remission at EOT, but that weight gain is both quicker and more 
consistent in FBT than is the case for AFT.
Le Grange et al. Page 5
Int J Eat Disord. Author manuscript; available in PMC 2015 March 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
The mechanisms of change in either FBT of AFT for adolescents with AN remain unclear. 
However, our findings do lend further support to our previous hypothesis regarding possible 
treatment mechanisms of action (5). For FBT, the active facilitation of early weight gain 
through parental efforts seems to have a positive impact on remission status. In AFT, the 
focus is on supporting the adolescent achieving self-efficacy and thereby reversing self-
starvation. It would appear that even in AFT, early weight gain through the adolescent’s 
own efforts can exert a positive impact of remission. Current research to improve therapy 
focuses on FBT, and whether adolescents with AN who fail to respond early on in FBT will 
benefit from this treatment if it is adapted to address the potential barriers to early response 
(12). This study is a first step to help clarify whether there are specific family or patient 
behaviors that complicate treatment from the get-go. Developing targeted treatment 
strategies early on in treatment in FBT, such as helping parents achieve a united effort 
toward weight restoration, or repeating the family meal early on in treatment to enhance 
parental re-feeding skills, may be particularly helpful and could prove outcome. What may 
help in AFT remains unexplored.
More research is also needed to describe whether early non-responders show certain 
characteristic profiles that are different from responders. Our study highlighted two factors, 
i.e., parental education for FBT and comorbid psychiatric diagnosis for AFT, which could 
potentially guide us in future efforts in this domain. Early responders in FBT have parents 
with relatively fewer years of education, whereas early responders in AFT are more likely to 
have no psychiatric comorbidity. It may be that higher parental education increases parents’ 
worry about psychological causes and the need to focus on them; or that parents with higher 
levels of education may have less time, because of work commitments, to focus on the tasks 
inherent to FBT. Also speculatively, the absence of psychiatric comorbidity may have 
enabled adolescents to more effectively engage in weight gain behaviors in AFT, given that 
this treatment may typically have a broader focus on issues other than the eating disorder. 
Therefore, this finding may suggest that AFT is less suitable for adolescents with complex 
psychiatric comorbidity, and with higher levels of impairment, which would render early 
weight gain difficult to achieve.
This study was limited by a relatively modest sample size. Still, it was the first to utilize data 
from a RCT of two psychosocial treatments for adolescent AN to examine early response to 
treatment and remission at EOT and 12-month follow-up. The definition of remission took 
both weight (% EBW) and concomitant psychological markers (EDE global score) into 
account. The importance of psychological change for long-term recovery (EDE) is important 
and consistent with our prior work on predictors of recovery (11). However, this study only 
examined the time to initial achievement of weight restoration and remission, and treatment 
gains were not always maintained across time. The results of this study may not generalize 
to clinical populations because all participants received one of two manualized treatments 
provided at two specialist treatment centers.
This study underscores that rapid and early weight gain in the treatment of adolescents with 
AN is associated with the likelihood of good outcome at EOT, and in a related study (11), 
EOT weight restoration predicts long term outcome in adolescent AN. However, other 
factors appear to be important for long-term remission. Future research might examine 
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alternative factors identifiable early in treatment that are associated with good outcome in 
the months following treatment completion. In particular, factors that can be directly 
modified or those that inform specific adaptations to treatment components could prove to 
be beneficial.
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Figure 1. 
Survival analysis comparing treatment conditions to predict weight restoration.
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